HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Physicochemical, Interaction & Topological Descriptors vs. hMAO-A Inhibition of Aplysinopsin Analogs: A Boulevard to the Discovery of Semi-synthetic Antidepression Agents.

AbstractBACKGROUND:
Depression, a neurological disorder, is globally the 4th leading cause of chronic disabilities in human beings.
OBJECTIVE:
This study aimed to model a 2D-QSAR equation that can facilitate the researchers to design better aplysinopsin analogs with potent hMAO-A inhibition.
METHODS:
Aplysinopsin analogs dataset were subjected to ADME assessment for drug-likeness suitability using StarDrop software before modeled equation. 2D-QSAR equations were generated using VLife MDS 4.6. Dataset was segregated into training and test set using different methodologies, followed by variable selection. Model development was done using principal component regression, partial least square regression, and multiple regression.
RESULTS:
The dataset has successfully qualified the drug-likeness criteria in ADME simulation, with more than 90% of molecules cleared the ideal conditions, including intrinsic solubility, hydrophobicity, CYP3A4 2C9pKi, hERG pIC50, etc. 112 models were developed using multiparametric consideration of methodologies. The best six models were discussed with their extent of significance and prediction capabilities. ALP97 was emerged out as the most significant model out of all, with ~83% of the variance in the training set, the internal predictive ability of ~74%, while having the external predictive capability of ~79%.
CONCLUSION:
ADME assessment suggested that aplysinopsin analogs are worth investigating. Interaction among the descriptors in the way of summation or multiplication products are quite influential and yield significant 2D-QSAR models with good prediction efficiency. This model can be used to design a more potent hMAO-A inhibitor with an aplysinopsin scaffold, which can then contribute to the treatment of depression and other neurological disorders.
AuthorsRajeev K Singla, Ghulam Md Ashraf, Magdah Ganash, Varadaraj Bhat G, Bairong Shen
JournalCurrent drug metabolism (Curr Drug Metab) Vol. 22 Issue 11 Pg. 905-915 ( 2021) ISSN: 1875-5453 [Electronic] Netherlands
PMID34779368 (Publication Type: Journal Article)
CopyrightCopyright© Bentham Science Publishers; For any queries, please email at [email protected].
Chemical References
  • Antidepressive Agents
  • Monoamine Oxidase Inhibitors
  • aplysinopsin
  • Tryptophan
  • Monoamine Oxidase
Topics
  • Antidepressive Agents (chemistry)
  • Computer Simulation
  • Humans
  • Monoamine Oxidase (metabolism)
  • Monoamine Oxidase Inhibitors (chemistry)
  • Quantitative Structure-Activity Relationship
  • Software
  • Tryptophan (analogs & derivatives, chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: